Item 5.07. Submission of Matters to a Vote of Security Holders

Shockwave Medical, Inc. (the "Company") held its Annual Meeting of Stockholders on June 23, 2022 (the "Annual Meeting"). Proxies for the Annual Meeting were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended. At the close of business on April 25, 2022, the record date for the Annual Meeting, there were 35,785,441 shares of the Company's common stock, par value $0.001 per share, outstanding and entitled to vote, and 31,963,071 of such shares were voted in person or by proxy at the Annual Meeting on the proposals described below.

At the Annual Meeting, the Company's stockholders voted on the following three proposals, each of which is described in more detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 29, 2022. The number of votes cast with respect to each proposal was as indicated below:

1.Election of Directors. The following nominees were elected to serve as Class III directors until the Company's 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified, or, if sooner, until the director's death, resignation or removal, based on the following results of voting:



       Nominee            Votes For        Vote Withheld        Broker Non-Votes
Doug Godshall             21,799,472         6,916,988             3,246,611
F.T. "Jay" Watkins        21,688,938         7,027,522             3,246,611
Frederic Moll, M.D.       19,387,707         9,328,753             3,246,611

2.Ratification of the Selection of the Independent Registered Public Accounting Firm. The selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2022 was ratified based on the following results of voting:



 Votes For        Votes Against       Abstentions        Broker Non-Votes
 31,819,908          123,840             19,323                N/A

3.Advisory Vote on the Compensation of the Company's Names Executive Officers. The compensation of the Company's named executive officers was approved, on an advisory basis, based on the following results of voting:



 Votes For        Votes Against       Abstentions        Broker Non-Votes
 27,185,083         1,504,980            26,397             3,246,611

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses